Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

Agilent Sues Twist Over Synthetic DNA

by Jean-François Tremblay
February 8, 2016 | A version of this story appeared in Volume 94, Issue 6

The synthetic DNA start-up Twist Bioscience is denying a claim by Agilent Technologies that Twist cofounder Emily Leproust stole trade secrets from Agilent. Leproust is a former Agilent chemistry R&D director who left the company in 2013 to cofound Twist. Like other synthetic DNA providers, Twist uses phosphoramidite chemistry. But instead of the standard 96-well plate, Twist does its chemistry in 10,000 nanowells on a silicon chip. Agilent’s complaint alleges that Leproust, while working for Agilent, used its resources, people, and proprietary information to develop Twist’s technology.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.